Clifford Chance has bolstered its Asia private funds offering with the recruitment of Liyong Xing, formerly a partner at Kirkland & Ellis.
Xing works with Asian fund sponsors on the structuring, formation, and governance of private investment funds across venture capital, growth capital, buyout, real estate, infrastructure, secondaries, and...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.